UniD Manufacturing

Executive Summary

UniD Manufacturing is a Belgian Contract Development and Manufacturing Organization (CDMO) exclusively focused on polymer-based long-acting drug delivery systems. Founded in 2015 and headquartered in Ghent, the company leverages over two decades of expertise to offer end-to-end services, from proof-of-concept through commercialization. Its technology platforms utilize non-biodegradable, biodegradable, and resorbable polymers to achieve sustained release durations ranging from one day up to nine years. UniD’s niche specialization positions it as a key partner for pharmaceutical companies seeking to differentiate their products via extended-release formulations, particularly in therapeutic areas requiring chronic or local drug administration.

Upcoming Catalysts (preview)

• Q4 2026New strategic partnership with a top-20 pharma for long-acting injectable program75% success
• H1 2027Announcement of capacity expansion at Ghent facility to meet growing demand80% success
• Q2 2027Client's lead candidate using UniD platform achieves Phase 3 milestone or regulatory submission60% success